Youngy Health Co Ltd

Youngy Health maintains a strong liquidity position, with a current ratio of 6.49, indicating the company can easily cover its short-term liabilities with its current assets. The company's liquidity_fpt score suggests a medium liquidity risk, which is consistent with its net cash position being negative after subtracting total debt. The debt-to-equity ratio of 0.07 reflects a conservative capital structure, with minimal reliance on debt financing.

Profitability metrics show a return on equity (ROE) of 6.57% and a return on assets (ROA) of 4.94%, which are below the industry median for Medical Equipment, Supplies & Distribution. The company's net income of 74.8 million CNY and operating income of 145.3 million CNY indicate a stable but not exceptional performance in terms of profitability. Gross profit of 332.3 million CNY suggests a moderate margin, which is in line with the industry's typical cost structure.

Youngy Health's revenue is not segmented by geographic region or product line in the available data, making it difficult to assess revenue concentration or diversification. However, the company's exposure to the domestic Chinese market is likely significant, given the lack of international revenue disclosure.

The company's growth trajectory appears to be modest, with no specific revenue growth rates provided in the available data. The capital expenditure of -9.87 million CNY suggests a reduction in investment in physical assets, which may indicate a focus on cost control or a shift toward more efficient operations. The free cash flow of 125.6 million CNY supports the company's ability to fund operations and potentially invest in growth opportunities.

Risk factors include a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could pose a challenge in maintaining liquidity under stress scenarios. The dilution risk is low, with no significant dilution sources identified in the available data.

Recent events include a reported last actual EPS of -0.89 CNY, which indicates a loss per share in the most recent reporting period. This suggests a decline in profitability, which may be a concern for investors and stakeholders.